231 related articles for article (PubMed ID: 27890659)
1. RNA nanoparticles harboring annexin A2 aptamer can target ovarian cancer for tumor-specific doxorubicin delivery.
Pi F; Zhang H; Li H; Thiviyanathan V; Gorenstein DG; Sood AK; Guo P
Nanomedicine; 2017 Apr; 13(3):1183-1193. PubMed ID: 27890659
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ
Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877
[TBL] [Abstract][Full Text] [Related]
3. A polyvalent aptamer system for targeted drug delivery.
Zhang Z; Ali MM; Eckert MA; Kang DK; Chen YY; Sender LS; Fruman DA; Zhao W
Biomaterials; 2013 Dec; 34(37):9728-35. PubMed ID: 24044994
[TBL] [Abstract][Full Text] [Related]
4. Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer.
Savla R; Taratula O; Garbuzenko O; Minko T
J Control Release; 2011 Jul; 153(1):16-22. PubMed ID: 21342659
[TBL] [Abstract][Full Text] [Related]
5. Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.
Shu D; Li H; Shu Y; Xiong G; Carson WE; Haque F; Xu R; Guo P
ACS Nano; 2015 Oct; 9(10):9731-40. PubMed ID: 26387848
[TBL] [Abstract][Full Text] [Related]
6. Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity.
Dou XQ; Wang H; Zhang J; Wang F; Xu GL; Xu CC; Xu HH; Xiang SS; Fu J; Song HF
Int J Nanomedicine; 2018; 13():763-776. PubMed ID: 29440899
[TBL] [Abstract][Full Text] [Related]
7. One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells.
He X; Hai L; Su J; Wang K; Wu X
Nanoscale; 2011 Jul; 3(7):2936-42. PubMed ID: 21623439
[TBL] [Abstract][Full Text] [Related]
8. RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo.
Baek SE; Lee KH; Park YS; Oh DK; Oh S; Kim KS; Kim DE
J Control Release; 2014 Dec; 196():234-42. PubMed ID: 25450401
[TBL] [Abstract][Full Text] [Related]
9. Aptamer-conjugated DNA icosahedral nanoparticles as a carrier of doxorubicin for cancer therapy.
Chang M; Yang CS; Huang DM
ACS Nano; 2011 Aug; 5(8):6156-63. PubMed ID: 21732610
[TBL] [Abstract][Full Text] [Related]
10. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
Moosavian SA; Abnous K; Badiee A; Jaafari MR
Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
[TBL] [Abstract][Full Text] [Related]
11. Tunneling Nanotubular Expressways for Ultrafast and Accurate M1 Macrophage Delivery of Anticancer Drugs to Metastatic Ovarian Carcinoma.
Guo L; Zhang Y; Yang Z; Peng H; Wei R; Wang C; Feng M
ACS Nano; 2019 Feb; 13(2):1078-1096. PubMed ID: 30608136
[TBL] [Abstract][Full Text] [Related]
12. Benzylguanidine and Galactose Double-Conjugated Chitosan Nanoparticles with Reduction Responsiveness for Targeted Delivery of Doxorubicin to CXCR 4 Positive Tumors.
Kong F; Tang C; Yin C
Bioconjug Chem; 2020 Oct; 31(10):2446-2455. PubMed ID: 32991164
[TBL] [Abstract][Full Text] [Related]
13. Targeted co-delivery of FOXM1 aptamer and DOX by nucleolin aptamer-functionalized pH-responsive biocompatible nanodelivery system to enhance therapeutic efficacy against breast cancer: in vitro and in vivo.
Masoudi M; Taghdisi SM; Hashemitabar G; Abnous K
Drug Deliv Transl Res; 2024 Jun; 14(6):1535-1550. PubMed ID: 38161196
[TBL] [Abstract][Full Text] [Related]
14. Enhanced tumor uptake and activity of nanoplex-loaded doxorubicin.
Zhao N; Leng Q; Woodle MC; Mixson AJ
Biochem Biophys Res Commun; 2019 May; 513(1):242-247. PubMed ID: 30954222
[TBL] [Abstract][Full Text] [Related]
15. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery.
Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L
Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044
[TBL] [Abstract][Full Text] [Related]
16. Enhanced targeting of 3D pancreatic cancer spheroids by aptamer-conjugated polymeric micelles with deep tumor penetration.
Tian L; Pei R; Zhong L; Ji Y; Zhou D; Zhou S
Eur J Pharmacol; 2021 Mar; 894():173814. PubMed ID: 33352182
[TBL] [Abstract][Full Text] [Related]
17. MUC1 aptamer-targeted DNA micelles for dual tumor therapy using doxorubicin and KLA peptide.
Charbgoo F; Alibolandi M; Taghdisi SM; Abnous K; Soltani F; Ramezani M
Nanomedicine; 2018 Apr; 14(3):685-697. PubMed ID: 29317345
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled aptamer-based drug carriers for bispecific cytotoxicity to cancer cells.
Zhu G; Meng L; Ye M; Yang L; Sefah K; O'Donoghue MB; Chen Y; Xiong X; Huang J; Song E; Tan W
Chem Asian J; 2012 Jun; 7(7):1630-6. PubMed ID: 22492537
[TBL] [Abstract][Full Text] [Related]
19. Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma.
Qiu R; Sun D; Bai Y; Li J; Wang L
Drug Deliv; 2020 Nov; 27(1):1704-1717. PubMed ID: 33305647
[TBL] [Abstract][Full Text] [Related]
20. Functional LAPONITE Nanodisks Enable Targeted Anticancer Chemotherapy
Wu Y; Li K; Kong L; Tang Y; Li G; Jiang W; Shen M; Guo R; Zhao Q; Shi X
Bioconjug Chem; 2020 Oct; 31(10):2404-2412. PubMed ID: 33001643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]